Dr. Meghan R. Flanagan is a breast surgical oncologist specializing in the treatment of patients with breast disease at the University of Washington as well as researcher at the Fred Hutchinson Cancer Center. Her clinical practice spans from the management of high risk and benign breast disease to advanced breast cancer. Her research aims to better understand the genomic signatures associated with tumor response to chemotherapeutic, endocrine and immunologic agents in the preoperative setting, and how to study and translate these findings to clinical care of patients at a population level.